A phase I and pharmacologic trial of sequential irinotecan as a 24-hour IV infusion, leucovorin [folinic acid], and flurouracil as a 48-hour IV infusion in adult cancer patients
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fluorouracil; Folinic acid; Irinotecan
- Indications Solid tumours
- Focus Adverse reactions
- 30 Apr 2015 Biomarkers information updated
- 25 Oct 2007 Status changed from in progress to completed.
- 31 May 2007 New trial record.